Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 18, Issue 2, Pages 299-307Publisher
FRONTIERS MEDIA SA
DOI: 10.1007/s12253-011-9444-1
Keywords
Pancreatic cancer; Galectins; Galectin-3; Expression
Funding
- Heidelberg Surgery Foundation
Ask authors/readers for more resources
Galectin-3 influences neoangiogenesis, tumor cell adhesion, and tumor-immune-escape mechanisms. Hence, the expression of galectin-3 in pancreatic ductal adenocarcinoma (PDAC) was evaluated. Galectin-3 expression in PDAC cell lines was proven by the presence of intracellular protein and by release into the supernatant. Furthermore, galectin-3 was found in the majority of human tissue samples. Serum concentrations of galectin-3 in PDAC patients did not differ significantly from healthy donors and did not correlate with established tumor markers. In conclusion, galectin-3 is expressed in PDAC tissues suggesting a role in tumor development; however, no relationship between expression and clinical findings could be established.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available